The Role of Body Mass Index (BMI) in Differentiated Thyroid Cancer: A Potential Prognostic Factor?

body mass index obesity outcome thyroid cancer tumor aggressiveness

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
29 Aug 2024
Historique:
received: 02 08 2024
revised: 21 08 2024
accepted: 26 08 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Obesity has been recognized as a potential risk factor for the carcinogenesis of differentiated thyroid cancer (DTC). The aim of this observational study was to investigate the prognostic role of BMI in influencing DTC histopathological aggressiveness and the risk of tumor relapse. We enrolled 257 patients with DTC, consecutively admitted to our Institution between January 2016 and December 2023. The following variables were collected: demographic, anthropometric and clinical parameters, risk factors for DTC, surgical and radioiodine therapy, histopathological features of DTC, and biochemical markers of disease. Tumor recurrence was assessed during short-, medium- and long-term follow-up. According to BMI tertiles (e.g; I: BMI < 23.3 kg/m

Identifiants

pubmed: 39335476
pii: biomedicines12091962
doi: 10.3390/biomedicines12091962
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Chiara Mele (C)

Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Lucrezia De Marchi (L)

Department of Endocrinology, UZ Brussel, Laarbeeklaan, 1090 Brussels, Belgium.

Giulia Marsan (G)

Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Marco Zavattaro (M)

Division of Endocrinology, University Hospital "Maggiore della Carità", 28100 Novara, Italy.

Maria Grazia Mauri (MG)

Division of Endocrinology, University Hospital "Maggiore della Carità", 28100 Novara, Italy.

Paolo Aluffi Valletti (P)

ENT Division, University of Piemonte Orientale, 28100 Novara, Italy.

Gianluca Aimaretti (G)

Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Paolo Marzullo (P)

Department of Translational Medicine, University of Piemonte Orientale, 28100 Novara, Italy.

Classifications MeSH